| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1086/517672 |
| P698 | PubMed publication ID | 9636889 |
| P50 | author | Jordi Rello | Q37370747 |
| P2093 | author name string | C Domingo | |
| D Mariscal | |||
| M Gallego | |||
| J Valles | |||
| M E Esandi | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | invasive pulmonary aspergillosis | Q54946623 |
| chronic obstructive pulmonary disease | Q199804 | ||
| P304 | page(s) | 1473-1475 | |
| P577 | publication date | 1998-06-01 | |
| P1433 | published in | Clinical Infectious Diseases | Q5133764 |
| P1476 | title | Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: report of eight cases and review | |
| P478 | volume | 26 |
| Q47619717 | A 7-year study of severe hospital-acquired pneumonia requiring ICU admission |
| Q46059175 | A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients |
| Q36439253 | A validated clinical approach for the management of aspergillosis in critically ill patients: ready, steady, go! |
| Q37943846 | Aspergillosis in the 'nonimmunocompromised' host |
| Q38199771 | Aspergillus tracheobronchitis in critically ill patients with chronic obstructive pulmonary diseases |
| Q35567147 | Clinical features of invasive bronchial-pulmonary aspergillosis in critically ill patients with chronic obstructive respiratory diseases: a prospective study |
| Q41998776 | Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients |
| Q53746276 | Detection of sputum Aspergillus galactomannan for diagnosis of invasive pulmonary aspergillosis in haematological patients. |
| Q44392075 | Disseminated aspergillosis in intensive care unit patients: an autopsy study |
| Q34688953 | Evaluation of MycAssay™ Aspergillus for diagnosis of invasive pulmonary aspergillosis in patients without hematological cancer |
| Q73235125 | Fungal Infections of the Lung |
| Q44790540 | Future role of micafungin in the treatment of invasive mycoses caused by filamentous fungi |
| Q38215670 | Identification and management of invasive mycoses in internal medicine: a road-map for physicians |
| Q43798573 | Immunoparalysis as a cause for invasive aspergillosis? |
| Q37717451 | Importance of Aspergillus spp. isolation in Acute exacerbations of severe COPD: prevalence, factors and follow-up: the FUNGI-COPD study. |
| Q36934706 | Infections in chronic lung diseases |
| Q49124894 | Invasive aspergillosis in critically ill patients: analysis of risk factors for acquisition and mortality |
| Q28306909 | Invasive aspergillosis in the intensive care unit |
| Q40494601 | Invasive pulmonary aspergillosis complicating septic shock |
| Q33918012 | Invasive pulmonary aspergillosis in acute exacerbation of chronic obstructive pulmonary disease and the diagnostic value of combined serological tests |
| Q51000077 | Invasive pulmonary aspergillosis in non-neutropenic patients: analysis of a 14-month prospective clinical experience. |
| Q37095685 | Invasive pulmonary aspergillosis in patients with COPD: a report of five cases and systematic review of the literature |
| Q51176004 | Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: an emerging fungal disease. |
| Q36307784 | Is Bulpa criteria suitable for the diagnosis of probable invasive pulmonary Aspergillosis in critically ill patients with chronic obstructive pulmonary disease? A comparative study with EORTC/ MSG and ICU criteria |
| Q33391938 | Isolation of Aspergillus lentulus in Spain from a critically ill patient with chronic obstructive pulmonary disease. |
| Q24811601 | Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome |
| Q44620423 | Lung aspergillosis. Role of the corticoids as associated risk factor in the patient with chronic bronchitis |
| Q37294689 | Management of invasive aspergillosis in patients with COPD: rational use of voriconazole. |
| Q36087577 | Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients |
| Q40164347 | Pseudomembranous aspergillar tracheobronchitis in a non-neutropenic critically ill patient in the intensive care unit |
| Q40417418 | Rapidly progressing dual infection with Aspergillus and Rhizopus: when soil inhabitants become deadly invaders |
| Q64131314 | Resumen de las recomendaciones terapéuticas para infecciones fúngicas en el paciente crítico no neutropénico: una visión multidisciplinar |
| Q51748116 | Survey of aspergillosis in non-neutropenic patients in Swiss teaching hospitals |
| Q38508539 | The use of biomarkers and molecular methods for the earlier diagnosis of invasive aspergillosis in immunocompromised patients |
| Q85178759 | Value of consecutive galactomannan determinations for the diagnosis and prognosis of invasive pulmonary aspergillosis in critically ill chronic obstructive pulmonary disease |
| Q36541263 | Ventilator-associated pneumonia: a review |
| Q76402196 | [Aspergillus and the lung] |
| Q80737382 | [Bronchopulmonary aspergillosis infections in the non-immunocompromised patient] |
| Q79385633 | [Invasive pulmonary aspergillosis in the non-neutropenic critical patient: future challenges] |
| Q73568246 | [The prognostic factors of invasive pulmonary aspergillosis in patients with chronic pneumopathy] |
Search more.